ACTA2 Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer.

Sunho Park John D Karalis Changjin Hong Jean R Clemenceau Matthew R Porembka In-Ho Kim Sung Hak Lee Sam C Wang Jae Ho Cheong Tae Hyun Hwang

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)

ACTA2 expression is associated with survival and ICI response in patients with gastric cancer. ACTA2 expression in CAFs, but not in other cellular compartments, appears to be associated with ICI response.

Keyphrases

poor prognosis
binding protein
long non coding rna